These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1926030

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fibrosing alveolitis.
    Thomas P.
    Can Med Assoc J; 1978 Nov 18; 119(10):1211-6. PubMed ID: 369671
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis.
    Holgate ST, Haslam P, Turner-Warwick M.
    Thorax; 1983 Jan 18; 38(1):67-70. PubMed ID: 6601861
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
    Johnston ID, Prescott RJ, Chalmers JC, Rudd RM.
    Thorax; 1997 Jan 18; 52(1):38-44. PubMed ID: 9039238
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.
    Turner-Warwick M, Burrows B, Johnson A.
    Thorax; 1980 Mar 18; 35(3):171-80. PubMed ID: 7385089
    [Abstract] [Full Text] [Related]

  • 36. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis.
    Nash JR, McLaughlin PJ, Butcher D, Corrin B.
    Histopathology; 1993 Apr 18; 22(4):343-7. PubMed ID: 8514277
    [Abstract] [Full Text] [Related]

  • 37. Cryptogenic fibrosing alveolitis: diagnosis and treatment.
    Egan JJ, Hasleton PS.
    Hosp Med; 1998 May 18; 59(5):364-8. PubMed ID: 9722386
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
    Kolek V.
    Acta Univ Palacki Olomuc Fac Med; 1994 May 18; 137():49-50. PubMed ID: 7778506
    [Abstract] [Full Text] [Related]

  • 39. Platypnoea-orthodeoxia in cryptogenic fibrosing alveolitis.
    Bourke SJ, Munro NC, White JE, Gibson GJ, Ashcroft T, Corris PA.
    Respir Med; 1995 May 18; 89(5):387-9. PubMed ID: 7638378
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.